Targeted probiotics with high efficacy.

SURI BioTech: Leading the Way in Probiotics Research and Winning International Awards

As a pioneering company in microbiome solutions, SURI BioTech has earned top honors at two major international competitions, reaffirming our leadership in microbiome research and development.

Our journey to success began with our victory at the Swiss Microbiomes Forum pitching competition in June 2023. This win was followed by another significant achievement at the 8th Microbiome Movement Drug Development Start-Up Showcase in 2023, held in Boston.

Our CEO Vanesa Rocha Martín, the winner of the 8th Microbiome Movement Drug Development start-up showcase 2023 receiving the price from the judges Denise Kelly, Emeritus Professor and Investor Advisor at Seventure, Brett Noel, Senior Associate at RA Capital Management, L.P., Sou Miyake, Head of Venture Investment at Corundum Systems Biology.


Both competitions featured esteemed panels of judges, including renowned scientists, investors, and experts of the microbiome field. Our triumphs in these competitions validate our focus and research strategy, earning recognition from leaders in the microbiome community.

At the heart of our success lies our commitment to innovation and scientific excellence. By harnessing the power of the microbiome, we aim to develop targeted probiotics as food ingredients and supplements that offer clear mechanisms of action. With a growing demand for microbiome-based products, SURI BioTech is well-positioned to drive meaningful advancements in nutrition and make a positive impact on global health.

Read More

Share this information

You Might Also be Interested